Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its ...

Fintel reports that on February 19, 2025, Mizuho upgraded their outlook for Glaukos (NYSE:GKOS) from Neutral to Outperform.

Purpose: To evaluate the change in corneal ... with cross-linking (in tPRK Xtra and FS-LASIK Xtra). Methods: The study included 143 eyes of 143 myopic, astigmatic patients that were divided into ...

The introduction of corneal cross-linking ... ophthalmic surgery and improving patient outcomes. The study shows that low-energy femtosecond lasers, such as the FEMTO LDV, produce smoother cut ...

Allogenic corneal inlays can be a safe solution for mild hyperopia and emmetropic presbyopia, according to an expert at the ...

We may earn commission on some of the items you choose to buy. As a result, there’s also a rising interest in collagen eye patches. Although collagen-infused eye masks aren’t usually able to ...

A PDUFA date has been set for October 20, 2025. If approved, Epoxia will be the first epi-on corneal crosslinking on the market.

Collagen supplements might make your skin more elastic – but the evidence is weak. Collagen is hugely hyped. This protein, which is important to the structure of skin and joints, has been ...

Texture: Oral capsule The Elemis Pro-Collagen line (spanning moisturizers, eye creams, and night treatments) has won enough awards and built such a stellar reputation that every skin care arsenal ...

Collagen supplements, often hailed as offering support for fitness and quality skin, are increasingly gaining traction. This key component is essential for skin, bones, and joints, and ...